医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

ALKBH5 deficiency suppresses hepatocarcinogenesis in mice via m6A-dependent STAT1 restoration

摘要RNA m6A methylation,as the most prevalent modification in mRNA,is a dynamic and reversible process primarily regulated by m6A methyltransferases("writers"),m6A demethylases("erasers"),and m6A recognition proteins("readers").It has been shown that N6-methyladenosine(m6A)plays a pivotal role in hepatocellular carcinoma(HCC).In this study we investigated the contribution of the m6A eraser AlkB homolog 5(ALKBH5)to hepatocarcinogenesis,particularly during the early stages of liver cancer development.We found that liver-specific Alkbh5 conditional knockout(Alkbh5-cKO)profoundly suppressed DEN/CCl4-induced HCC tumorigenesis and development in mice.We further showed that exogenous ALKBH5 expression drove the malignant transformation of immortal normal hepatocytes(HHL5,BNL),whereas ALKBH5 depletion in HCC cells restored hepatocyte-specific functions and suppressed malignancy.By conducting integrated MeRIP-seq/RNA-seq analyses,we identified STAT1 as a key target of ALKBH5-mediated m6A demethylation.ALKBH5 directly bound to STAT1 mRNA and reduced its m6A modification,thereby decreasing mRNA stability and suppressing STAT1 expression.Downregulated STAT1 inactivated the hepatocyte nuclear factor FOXA3,blocking hepatic differentiation and promoting malignancy.In 42 pairs of clinical HCC samples analyzed,STAT1 was negatively correlated with ALKBH5,and HCC patients with high ALKBH5 and low STAT1 expression exhibited worse clinical outcomes.We conclude that ALKBH5 is a critical oncogene in hepatocarcinogenesis.These results provide novel insights into the epigenetic regulation of hepatocarcinogenesis.

更多
广告
作者单位 Department of Oncology,Fudan University Shanghai Cancer Center,Shanghai 200032,China;School of Life Sciences,Institute of Metabolism and Integrative Biology,Fudan University,Shanghai 200438,China [1] Department of Oncology,Fudan University Shanghai Cancer Center,Shanghai 200032,China [2] The International Cooperation Laboratory on Signal Transduction,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200438,China [3] Institute of Molecular Medicine(IMM),Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai Jiao Tong University,Shanghai 200240,China [4] The International Cooperation Laboratory on Signal Transduction,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200438,China;National Center for Liver Cancer,Shanghai 200441,China [5] The International Cooperation Laboratory on Signal Transduction,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200438,China;National Center for Liver Cancer,Shanghai 200441,China;Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer(SMMU),Ministry of Education,Shanghai 200438,China;Shanghai Key Laboratory of Hepatobiliary Tumor Biology(EHBH),Shanghai 200438,China [6] Department of Oncology,Fudan University Shanghai Cancer Center,Shanghai 200032,China;School of Life Sciences,Institute of Metabolism and Integrative Biology,Fudan University,Shanghai 200438,China;National Center for Liver Cancer,Shanghai 200441,China [7]
栏目名称
DOI 10.1038/s41401-025-01631-6
发布时间 2026-01-23(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览0
  • 下载0
中国药理学报(英文版)

中国药理学报(英文版)

2026年47卷1期

209-221页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷